Results 241 to 250 of about 9,499,844 (341)
Objective The effect of the shared epitope (SE) and valine at position 11 (Val11) of HLA–DRB1 on the activation of CD4+ T cells is expected to be diminished by abatacept, a costimulation blocker. However, published evidence on the value of genetic stratification for abatacept treatment is conflicting. We aimed to compare the difference in effectiveness
Chuan Fu Yap +14 more
wiley +1 more source
Sexual Health, Pleasure, Justice, and Well-Being in People With Rheumatic and Musculoskeletal Diseases: A Scoping Review Protocol. [PDF]
Giardulli B +9 more
europepmc +1 more source
Background Polymyalgia rheumatica (PMR) is an age‐related inflammatory disease with shoulder‐hip girdle involvement. Magnetic resonance imaging (MRI) reveals extracapsular/entheseal soft tissue involvements in both PMR and spondyloarthritis (SpA) with sacroiliac joint and peri‐entheseal spinal bone marrow oedema (BMO) being characteristic of SpA ...
Kerem Abacar +12 more
wiley +1 more source
The Efficacy of Virtual Reality on the Rehabilitation of Musculoskeletal Diseases: Umbrella Review.
Tang P +6 more
europepmc +1 more source
Cellular Senescence: The Driving Force of Musculoskeletal Diseases. [PDF]
Falvino A +8 more
europepmc +1 more source
Clinical Images: Subcutaneous panniculitis‐like T cell lymphoma
Arthritis &Rheumatology, EarlyView.
S Chambers, CN Myrdal, VP Werth
wiley +1 more source
B cells and systemic sclerosis interstitial lung disease
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman +2 more
wiley +1 more source
Cell-based therapy in the treatment of musculoskeletal diseases. [PDF]
Trapana J +7 more
europepmc +1 more source
Work disability and musculoskeletal disease [PDF]
openaire +3 more sources

